Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) were down 10.7% during trading on Monday . The company traded as low as C$0.12 and last traded at C$0.12. Approximately 252,156 shares were traded during trading, an increase of 149% from the average daily volume of 101,128 shares. The stock had previously closed at C$0.14.
Voyageur Pharmaceuticals Price Performance
The company has a quick ratio of 0.84, a current ratio of 0.18 and a debt-to-equity ratio of 6.05. The stock has a market cap of C$22.43 million, a PE ratio of -12.50 and a beta of 0.78. The firm has a fifty day moving average of C$0.10 and a 200 day moving average of C$0.13.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Recommended Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- 3 Big Banks Plan Double Digit Dividend Increases After Passing Fed Stress Test
- 3 ETFs Offering Exposure to Latin America’s Stock Market Rally
- Could Apple’s China Play Be the Answer to Its Memory Pressure Problem?
- 3 Charts That Could Change the Course of Summer Trading
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
